TIMP2 and acute kidney injury: Recently, the combination of two cell-cycle arrest biomarkers, insulin growth factor binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinase 2 (TIMP-2), has been proposed to predict the onset of severe AKI with significantly greater accuracy than other biomarkers [20].